Abbott Laboratories remains a "Buy," anticipating double-digit growth, despite near-term volatility and underwhelming 2026 ...
Abbott Laboratories will separate its nutrition business into an independent, publicly traded company via a tax-free spin-off by the end of 2027, ...
“It feels like an unnecessary test that won't obtain the result that they're after, and it could cost our residents a lot of ...
The last 12 months at Abbott Laboratories (NYSE:ABT) has been defined by a bold bet that put at risk the reputation it has carried for decades as a medtech ...
Abbott Laboratories (NYSE:ABT) is one of the top 10 picks in President Trump’s latest stock portfolio. Trump bought $1 ...
Democrats are almost certainly going to win the House, but may not carry not the Senate, says elections forecaster G. Elliott ...
Texas wildcatters, oilfield services giants, and U.S. Energy Secretary Chris Wright helped Australia's Beetaloo Basin deliver ...
If the worst thing you can say about these judges is that a team of Abbott’s in-house lawyers vetted them and found them fit to serve the public, then voters in both parties should rest easy.
Restaurant Week is back and better than ever for its 18th year. Get your toothpicks ready and put on your bib because it’s ...
VisionQuest concludes the trilogy that continued in 2024 with Agatha All Along and follows not Wanda Maximoff but Vision, her ...